EP4237026C0 - Verfahren zur herstellung von vernetztem und optional geformtem gewebe mit selektiver einstellung von dicke, form und/oder flexibilität - Google Patents

Verfahren zur herstellung von vernetztem und optional geformtem gewebe mit selektiver einstellung von dicke, form und/oder flexibilität

Info

Publication number
EP4237026C0
EP4237026C0 EP21794891.8A EP21794891A EP4237026C0 EP 4237026 C0 EP4237026 C0 EP 4237026C0 EP 21794891 A EP21794891 A EP 21794891A EP 4237026 C0 EP4237026 C0 EP 4237026C0
Authority
EP
European Patent Office
Prior art keywords
flexibility
linked
thickness
shape
selective adjustment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP21794891.8A
Other languages
English (en)
French (fr)
Other versions
EP4237026B1 (de
EP4237026A1 (de
Inventor
Alexander Rzany
Christine Mueller
Nina Foh
Judith Flore Solowiej
Bernhard Hensel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik AG
Original Assignee
Biotronik AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotronik AG filed Critical Biotronik AG
Publication of EP4237026A1 publication Critical patent/EP4237026A1/de
Application granted granted Critical
Publication of EP4237026B1 publication Critical patent/EP4237026B1/de
Publication of EP4237026C0 publication Critical patent/EP4237026C0/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
EP21794891.8A 2020-10-30 2021-10-28 Verfahren zur herstellung von vernetztem und optional geformtem gewebe mit selektiver einstellung von dicke, form und/oder flexibilität Active EP4237026B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20205069 2020-10-30
PCT/EP2021/080040 WO2022090420A1 (en) 2020-10-30 2021-10-28 Method for the production of crosslinked and optionally shaped tissue with selective adjustment of thickness, shape and/or flexibility

Publications (3)

Publication Number Publication Date
EP4237026A1 EP4237026A1 (de) 2023-09-06
EP4237026B1 EP4237026B1 (de) 2024-12-04
EP4237026C0 true EP4237026C0 (de) 2024-12-04

Family

ID=73288354

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21794891.8A Active EP4237026B1 (de) 2020-10-30 2021-10-28 Verfahren zur herstellung von vernetztem und optional geformtem gewebe mit selektiver einstellung von dicke, form und/oder flexibilität

Country Status (3)

Country Link
US (1) US20230390050A1 (de)
EP (1) EP4237026B1 (de)
WO (1) WO2022090420A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022018728A (ja) * 2020-07-16 2022-01-27 住友化学株式会社 ガス分離膜用の樹脂組成物及びガス分離膜

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141064B2 (en) 2002-05-08 2006-11-28 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
US8105375B2 (en) 2007-01-19 2012-01-31 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US8136218B2 (en) * 2008-04-29 2012-03-20 Medtronic, Inc. Prosthetic heart valve, prosthetic heart valve assembly and method for making same
US8846390B2 (en) 2010-03-23 2014-09-30 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
EP2926840B1 (de) 2014-04-02 2018-05-09 Biotronik AG Verfahren zur Aufbereitung von biologischem Gewebe zur trockenen Verwendung in einem Implantat
DE102015117318A1 (de) * 2015-10-12 2017-04-13 Biotronik Se & Co. Kg Verfahren zur Dickenkontrolle und dreidimensionalen Formgebung von biologischem Gewebe während der Fixierung

Also Published As

Publication number Publication date
EP4237026B1 (de) 2024-12-04
WO2022090420A1 (en) 2022-05-05
EP4237026A1 (de) 2023-09-06
US20230390050A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
EP3778811A4 (de) Bewuchshemmender beschichtungsfilm und verfahren zur herstellung davon, wasserberührende struktur mit bewuchshemmendem beschichtungsfilm sowie bewuchshemmendes band und verfahren zur herstellung davon
EP4223707A4 (de) Wasserverarbeitungsverfahren, wasserverarbeitungssystem, karbonisierungs-/verbrennungsmaterial und verfahren zur herstellung von karbonisierungs-/verbrennungsmaterial
EP4181858A4 (de) Biologisch abbaubare mikrokapseln. verfahren zur herstellung davon und verfahren zur verwendung davon
EP4436364A4 (de) Tobrfv-tolerante oder resistente pflanzen und verfahren zur herstellung davon
EP4052591A4 (de) Verfahren zur herstellung von tempe-haltiger sauce und daraus hergestellte sauce
EP4130326A4 (de) Stahlblech, element und verfahren zur herstellung davon
EP4087862A4 (de) Antitigit-antikörper, multispezifische antikörper, die dieseelben umfassen, und verfahren zur verwendung derselben
EP4438722A4 (de) Menschliche induzierbare t-zelle und verfahren zur herstellung davon
EP4350013A4 (de) Nichtorientiertes elektromagnetisches stahlblech und verfahren zur herstellung davon
EP4279618A4 (de) Martensitbasiertes edelstahlmaterial und verfahren zur herstellung davon
EP4204641A4 (de) Gebäudeoberflächenprodukt mit befestigungsklammer, gebäudeoberflächensystem und verfahren zur herstellung
EP4206220C0 (de) Proinsulinglargin und verfahren zur herstellung von insulinglargin daraus
EP4237026C0 (de) Verfahren zur herstellung von vernetztem und optional geformtem gewebe mit selektiver einstellung von dicke, form und/oder flexibilität
EP4382552A4 (de) Vernetztes elastomer und verfahren zur herstellung davon
EP4330362C0 (de) Verwendung und verfahren zur herstellung von mono-rhamnolipiden
EP4330418C0 (de) Verwendung und verfahren zur herstellung von mono-rhamnolipiden
EP3889296C0 (de) Hochfestes stahlblech mit hervorragender duktilität und tieftemperaturbeständigkeit sowie verfahren zur herstellung davon
EP4109638A4 (de) Elektrochemisches element und verfahren zur herstellung davon
EP4382661A4 (de) Kunstleder und verfahren zur herstellung davon
EP4284408A4 (de) Verfahren zur herstellung von sekretomen und verwendungen davon
EP3536830C0 (de) Verfahren zur herstellung von lederähnlichen stoff sowie dadurch erhältlicher lederähnlicher stoff
EP3633100C0 (de) Genarbtes kunstleder und verfahren zur herstellung von genarbtem kunstleder
EP4269691A4 (de) Zellstoffgeformter artikel und verfahren zur herstellung davon
EP4241796A4 (de) Biokompatibles material und verfahren zur herstellung davon
EP4179879A4 (de) Verfahren zur herstellung von texturiertem proteinmaterial und texturiertes proteinmaterial

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230505

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240607

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602021022974

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20241212

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

Effective date: 20241223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250404

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241204

U1N Appointed representative for the unitary patent procedure changed after the registration of the unitary effect

Representative=s name: WSL PATENTANWAELTE PARTNERSCHAFT MBB; DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20250905

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 5

Effective date: 20251015

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20251022

Year of fee payment: 5